Business Monitor International, March 2011, Pages: 102
Business Monitor International's VietnamPharmaceuticals and HealthcareReport provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government
Business Monitor International, Dec 2009, Pages: 88
)
- Vidipha Central Pharmaceutical Joint Stock Company VietnamPharmaceuticals and HealthcareReportQ1 2010
Business Monitor International, Oct 2007, Pages: 63
- Vietnam OPV Pharmaceutical Co
- VietnamPharmaceutical Corporation (Vinapharm)
VietnamPharmaceuticals and HealthcareReportQ3 2007
Business Monitor International, Feb 2009, Pages: 82
VietnamPharmaceuticals and HealthcareReport provides independent forecasts and competitive intelligence on Vietnam's pharmaceuticals and healthcare industry.
Vietnam’s US$1.2bn pharmaceutical
Business Monitor International, April 2009, Pages: 79
Pharmaceutical Joint Stock Company (Ampharco)
- Vidipha Central Pharmaceutical Joint Stock Company VietnamPharmaceuticals and HealthcareReportQ2 2009
Business Monitor International, Sep 2008, Pages: 74
Stada VietnamVietnamPharmaceutical Joint Stock Company (Ampharco)
Vidipha Central Pharmaceutical Joint Stock Company VietnamPharmaceuticals and HealthcareReportQ3 2008
Business Monitor International, May 2008, Pages: 65
OPV Pharmaceutical Co
- Stada Vietnam
- Vidipha Central Pharmaceutical Joint Stock Company
VietnamPharmaceuticals and HealthcareReportQ2 2008
Datamonitor, Aug 2010, Pages: 125
The pharmaceutical drug market grows amid a poor healthcare system in Vietnam
Government participation in healthcare
Key health concerns
Pharmaceutical market structure
3. Overview of M&A activity
Key findings
Business Monitor International, July 2010, Pages: 43
.7 out of 100 on BMI's Pharmaceuticals & Healthcare BERs for Q310. This makes it the region’s 14th most attractive market, behind Vietnam (42.1) and ahead of Bangladesh (39.7). Sri Lanka scores above